FDA Approves 12-Month Shelf Life for Taxus(R) Stent System
Mon, 23 May 2005 04:00 AM EST
... Boston ScientificCorporation (NYSE: BSX) announces that the US Food and DrugAdministration (FDA) has approved extending the shelf life of its TAXUS(R)Express2(TM) paclitaxel-eluting coronary stent system in the United States totwelve months from the current shelf life of nine months... click link for more info. ...
Related Topics
- Carbetapentane and Chlorpheniramine
- Immune System
- Digestive System
- Endocrine System
- Health System
- Chlorpheniramine and Carbetapentane
- Critical Care
- Trauma
- Mammography
- Nutrition
- Life Table Analysis System
- Nutrition & Physical Acitvity Surveys & Monitoring Systems
- Angioplasty
- Carbetapentane and Chlorpheniramine oral suspension
- Dental Health
- Amoxicillin
- Leuprolide Depot Injection
- Carbetapentane, Phenylephrine, and Pyrilamine
- Carbetapentane, Phenylephrine, and Pyrilamine oral suspension
- Death And Dying

Not Signed In -


